β1 integrin monoclonal antibody treatment ameliorates cerebral cavernous malformations is a research paper published in The FASEB Journal (2022). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Neurological Disorders and Stroke
Grant: NS092521
NHLBI Division of Intramural Research
Grant: P01HL151433
NHLBI Division of Intramural Research
Grant: 5T32HL086344
NHLBI NIH HHS
Grant: T32 HL086344
NINDS NIH HHS
Grant: P01 NS092521
NINDS NIH HHS
Grant: P30 NS047101
NHLBI NIH HHS
Grant: R35 HL139947
National Institutes of Health
Grant: 5P30NS047101-07
project 1
National Institutes of Health
Grant: 1P01HL151433-01
Cellular Mechanisms of Inflammation, Hemostasis, and Thrombosis
National Institutes of Health
Grant: 5T32HL086344-08
Blood Cells in Hemostasis and Thrombosis
FWCI
0.59
Citation Percentile
0.7%
Influential Citations
1
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals